2026-05-15 02:32:27
Latest Post
Deep Industries Ltd consolidated Q4 FY2025-26 loss at Rs. 14.35 crores
Data Patterns India Ltd Q4FY26 PAT climbs to Rs. 138.38 crores
KRBL Ltd posts consolidated PAT of Rs. 155.38 crores in Q4 FY26
Pitti Engineering Ltd consolidated Q4 FY2026 profit declines to Rs. 26.61 crores
Mukand Ltd reports consolidated PAT of Rs. 554.98 crores in Q4 FY2026
Stock Report
Akums Drugs and Pharmaceuticals Ltd consolidated Q4 FY2025-26 profit at Rs. 87.40 crores
Posted On : 2026-05-14 19:18:01( TIMEZONE : IST )
Akums Drugs and Pharmaceuticals Limited has reported Consolidated financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 1193.169 crores during the period ended March 31, 2026 as compared to Rs. 1193.915 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 84.613 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 66.317 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 5.53 for the period ended March 31, 2026 as compared to Rs. 4.33 for the period ended December 31, 2025.
| Financials | Q4 FY2026 | Q3 FY2026 | % Change |
| Total Income | ₹ 1193.169 crs | ₹1193.915 crs |  -0.06% |
| Net Profit | ₹84.613 crs | ₹66.317 crs |  27.59% |
| EPS | ₹5.53 | ₹4.33 | 27.71% |
Financial Results (Q4 FY2026) - YoY Comparison
The company has reported total income of Rs. 1193.169 crores during the period ended March 31, 2026 as compared to Rs.1073.092 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.84.613 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.147.617 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.5.53 for the period ended March 31, 2026 as compared to Rs.9.64 for the period ended March 31, 2025.
| Financials | Q4 FY2026 | Q4 FY2025 | % Change |
| Total Income | ₹ 1193.169 crs | ₹1073.092 crs | 11.19% |
| Net Profit | ₹84.613 crs | ₹147.617 crs | -42.68% |
| EPS | ₹5.53 | ₹9.64 | -42.63% |
Financial Results (Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.4487.742 crores during the Financial Year ended March 31, 2026 as compared to Rs.4170.280 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.255.188 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.338.176 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.16.67 for the Financial Year ended March 31, 2026 as compared to Rs.22.60 for the Financial Year ended March 31, 2025.
| Financials | Year Ended FY2026 | Year Ended FY2025 | % Change |
| Total Income | ₹4487.742 crs | ₹4170.280 crs | 7.61% |
| Net Profit | ₹255.188 crs | ₹338.176 crs | -24.54% |
| EPS | ₹16.67 | ₹22.60 | -26.24% |
Shares of Akums Drugs and Pharmaceuticals Limited was last trading in BSE at Rs. 526.40 as compared to the previous close of Rs. 540.95. The total number of shares traded during the day was 40133 in over 2650 trades.
The stock hit an intraday high of Rs. 558.00 and intraday low of 512.20. The net turnover during the day was Rs. 21584813.00.
